Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Neurology > Dementia > Flashcards

Dementia Flashcards

1
Q

What is dementia?

A

Umbrella term used to describe a range of symptoms associated with cognitive impairment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the syndrome of dementia itself.

A
  • Chronic, acquired global decline in brain functions.
  • Usually progressive and irreversible.
  • Neuropsychological deficits:
    • ​Amnesia (memory)
    • +
    • Aphasia (communication)
    • Apraxia (motor execution)
    • Agnosia (recognition)
    • Executive function (synthesis)
    • +
  • Significant deterioration in activities of daily living (ADLs):
    • ​Instrumental
    • Basic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the differential diagnoses of dementia-like symptoms?

A
  • Delirium (acute)
  • Depression
    • Low mood, poor concentration, ‘don’t know’ answers, good orientation.
  • MCI
    • Amnestic, ADLs intact.
  • Normal ageing
    • Person aware and concerned, WFD, important things are rememebered and function is preserved.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the basic brain anatomy outlining which areas of the brain are responsible for which functions.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which area of the brain is implicated in dementia?

A

The hippocampus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the frontal lobe responsible for?

How do you test this?

A
  • Executive function
  • Planning (e.g. clock drawing)
  • Sequencing (luria)
  • Fluency (naming words beginning with the same letter)
  • Cognitive estimates
  • Initiative
  • Inhibition
  • Personality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the temporal lobes responsible for?

How do you test this?

A
  • Memory
  • Speech (left)
  • Address test
  • Object recall
  • Serial 7s (deduct 7 from 100 and keep subtracting), spelling
  • Phrase repetition (fluent receptove aphasia)
  • Mood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the parietal lobes responsible for?

How do you test this?

A
  • Spatial awareness (R)
  • Language (L)
  • Serial 7s (L)
  • Clock drawing - shared between the parietal and frontal lobe
  • Naming objects (pen, watch), severe nominal (expressive) dysphasia.
  • 3-stage command (dyspraxia).
  • Copying cube and interlocking shapes (visuospatial agnosia and constructed dyspraxia) (R).
  • Writing a sentence (L).
  • Agnosia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which test can be used to monitor dementia?

A
  • Mini-mental state examination.
  • Dementia patients lose approximately 3 points per year in the test.
  • Problem is that is has been copyrighted so is no longer in popular use.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does the MoCA test?

A
  • Sensotivity = 90%
  • Specificity = 87%
  • Short term memory
  • Recall
  • Visuospatial abilities
  • Executive function
  • Attention
  • Concentration
  • Working memory
  • Language
  • Orientation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does the TYM test?

A
  • Orientation
  • Ability to copy a sentence
  • Semantic knowledge
  • Calculation
  • Verbal fluency
  • Similarities
  • Visuospatial abilities
  • Recall of copied sentence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the Addenbrookes Cognitive Examination.

A
  • 20-25 minutes
  • Multi-domain
  • Good reliability
  • Cut-off 82/100
    • Sensitivity 0.93
    • Specificity 1
  • Cut-off 88/100
    • Sensitivity 1
    • Specificity 0.96
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 3 stages of dementia?

A
  • Preclinical - changes in biomarkers.
  • MCI - biomarkers may help determine progression to Alzheimer’s disease.
  • Alzheimer’s disease - biomarkers may be helpful in excluding AD as a cause.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the timeline of disease progression.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What defines mild cognitive impairment?

A
  • Subjective memory impairment and cognitive impairment not meeting dementia diagnostic criteria and in particular with no impairment in core ADLs.
  • Amnestic MCI in which the prominent impairment is one of memory has a conversion rate from 10-15% per year in clinic-based studies.
  • Conversion is not inevitable, up to 25% in some studies show subsequent recovery of normal cognitive function.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the benefits of early diagnosis of dementia?

A
  • Disease modifying effect better than targeting MCI
  • Slowing of cognitive decline
  • Better quality of life
  • Better adjustment for disability
  • Future planning
  • Reduced strain on carer
  • Reduced strain on services
17
Q

What are the risk factors for Alzheimer’s disease?

A
  • Age
  • Lack of exercise
  • Smoking
  • High cholesterol
  • Hypertension
  • Poorly controlled Diabetes
  • Family history
  • Education and social engagement
  • Depression
  • Head injury
  • Hearing loss
18
Q

What are the protective factors for Alzheimer’s disease?

A
  • Mediterranean diet
  • Physical activity
  • Minimising vascular risks
  • Social activity
  • Lifelong learning
19
Q

Describe the pathophysiology of Alzheimer’s disease.

A
  • Senile plaques, neurofibrillary tangles and cell death.
  • Reduction of acetyl choline reduces neuronal signalling.
  • Presence of glutamate in the wrong place interferes with signalling.
20
Q

What is the clinical picture of Alzheimer’s disease?

A
  • Insidious onset and slow steady progression
  • Memory deficits, language, visual-spatial
  • Disorientation
  • Decline in self care
  • Executive decline
  • Apathy
21
Q

Describe the clinical picture of vascular dementia.

A
  • Less insidious onset
  • Stepwise decline
  • Emotional lability
  • Preserved personality
  • CVD (brain infarcts)
  • Vascular risk factors
22
Q

What are the risk factors for vascular dementia?

A
  • Age
  • Lack of exercise
  • Smoking
  • High cholesterol
  • Hypertension
  • Poorly controlled Diabetes
23
Q

Describe dementia with Lewy bodies.

A
  • Fluctuating course
  • Visual hallucinations
  • Postural instability
  • Parkinsonism
  • Sensitivity to antipsychotics
  • Memory relatively preserved
  • DaTSCAN can be of use
24
Q

Describe frontotemporal dementia.

A
  • Personality changes
  • Behavioural changes
  • Language problems
  • Memory relatively preserved
  • Younger onset
  • AChEI not effective
25
Q

What are the other types of dementia?

A
  • cc 100
  • Alcohol related
  • Huntington’s
  • MS
  • Down’s syndrome
  • Corticobasal degeneration
  • Prion disease
  • Parkinson’s disease
26
Q

Describe the assessment and diagnosis of dementia.

A
  • Screening tests identify 90% but don’t establish the diagnosis.
  • Dementia is diagnosed when progressive cognitive decline has occurred and this has had noticeable impacts upon a person’s ability to carry out important everyday activities.
  • Informant interview
    • This is often one of the most important issues in the diagnostic process allowing someone close to the patient to describe any changes that they have noticed in the memory abilities or level of functioning in the patient
    • A structured informant questionnaire may be used (eg IQCODE, p48 SIGN86)
    • Neuropsychiatric Inventory; Bristol ADL Scale
  • Specialist Assessments
  • Consideration of the need for further specialist input including:
    • Psychometric assessment (Clinical Psychologist)
    • Assessment of ADLs, Claudia Allen Test (OT)
    • Assessment and management of Language & Speech (SALT)
    • Neurological assessment (Neurologist)
    • Significant medical co-morbidity or frailty (MftE)
  • Diagnostic Confirmation
    • Dementia diagnosis made following reference to ICD or DSM

diagnostic schedules (eg p34-40 SIGN86)

27
Q

Which tests can be done when you suspect dementia?
What might these tests show?

A
28
Q

Describe the use of neuroimaging in patients with dementia.

A
29
Q

Describe the pathology associated with Alzheimer’s disease.

A
30
Q

Describe the management of dementia.

A
  • Acetylcholinesterase inhibitors approved (NICE) in mild to moderate dementia (AD, DLB, PD, even VaD) may slow progression and help behavioural sy, and 10-25% may improve:
    • Donepezil (Aricept)
    • Rivastigmine (Exelon) Galantamine (Reminyl)
  • NMDA receptor antagonists eg Memantine (Ebixa) licenced in moderate to severe AD slows rate of decline and helps behavioural symptoms
  • Combination may be used in moderate to severe dementia
  • Stopping medication may cause more rapid decline
  • No medication for MCI
31
Q

What ‘treatments’ are NOT beneficial in dementia?

A
  • Vitamin B6, B12, E, folate, souvenaid
  • Ginko biloba
  • Coconut oil
  • Hormones (testosterone, estrogen)
  • Statins
  • Aspirin and other NSAIDs
  • Vaccines
32
Q

How long are patients likely to survive after symptom onset in Alzheimer’s disease?

A

9-12 years

33
Q

What are the big considerations when managing a patient with Alzheimer’s disease?

A
  • Maintaining independence
  • Managing risk
  • Co-morbidities
  • Behavioural management
  • Cognitive stimulation
  • Reminiscence therapy
  • Supporting the carers
34
Q

What are the behavioural and psychological symptoms of dementia?

A
  • 90% patients have symptoms
  • Present throughout the course of the disease
  • More common with disease progression
  • Remitting but highly recurrent (6 week cycle)
  • Very problematic aspect for carers and major source of career distress
  • Strongly associated with nursing home placement

Neurology (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions